Skip to main content
. 2023 Jun;27(6):444–450. doi: 10.5005/jp-journals-10071-24481

Table 4.

Antibiotics used in the ceftazidime-avibactam and polymyxin (B/E) groups

Study group
Group A (n = 78) Group B (n = 26) All (n = 104) p-value
Additional agent used Aztreonam
Meropenem
Fosfomycin
Tigecycline
Meropenem + tigecycline
Minocycline
n (%) 48 (61.5)
0 (0)
0 (0)
0 (0)
0 (0)
0
0
9 (34.6)
7 (26.9)
2 (7.7)
3 (11.5)
5 (19.2)
48 (46.1)
9 (8.6)
7 (6.7)
2 (1.9)
3 (2.9)
5 (4.8)
Additional treatment duration (days) Median (range)§ 8 (4–14) 8 (5–15) 8 (4–15) 0.908NS

§p-value by Mann–Whitney U test; the rest of the p-values by Chi-square test or Fisher's exact probability test. p-value < 0.05 is considered to be statistically significant. NS, statistically non-significant